Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-06-05
1997-09-02
Kight, John
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536123, 53612312, 536127, 4352551, 4352552, C07H 100, C07H 106, C08B 3700, C12P 1904
Patent
active
056633246
ABSTRACT:
A method for producing soluble preparations of neutral glucan polymers is disclosed. The method involves treating whole glucan particles with a unique sequence of acid and alkaline treatments to produce soluble glucan. The soluble glucan can be purified to obtain a physiologically acceptable solution of neutral glucan molecules. A soluble neutral glucan preparation is obtained which forms a clear solution at a neutral pH and is equilibrated in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 3943247 (1976-03-01), Komatsu et al.
patent: 4138479 (1979-02-01), Truscheit et al.
patent: 4237266 (1980-12-01), Sugiura et al.
patent: 4707471 (1987-11-01), Larm et al.
patent: 4739046 (1988-04-01), Diluzio et al.
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
patent: 5028703 (1991-07-01), Jamas et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5320849 (1994-06-01), Hagiwara et al.
patent: 5322841 (1994-06-01), Jamas et al.
Janusz, et al., J. Immunol., vol. 137, No. 10, issued Nov. 15, 1986, pp. 3270-3276.
Manners et al., Biochem. J., vol. 135, issued 1973, pp. 19-30.
Williams et al., Chemical Abstracts, vol. 109, issued 1988, abstract No. 66566q.
Bacon et al, Biochem. J., vol. 114, issued 1969, pp. 557-567.
Fleet et al., Chemical Abstracts, vol. 85, issued 1976, abstract No. 89819z.
Janusz, M.J. et al., "Isolation of Soluble Yeast .beta.-Glucans That Inhibit Human Monocyte Phagocytosis Mediated by .beta.-Glucan Receptors," J. Immunol. 137: 3270-3276 (Nov. 15, 1986).
Manners, D.J. et al., "The Structure of a .beta.-(1-3)-D-Glucan from Yeast Cell Walls," Biochem. J. 135: 19-30 (1973).
Fleet, G.H., et al., "Isolation and Composition of an Alkali-Soluble Glucan from the Cell Walls of Saccharomyces cerevisiae," Journal of General Microbiology, 94: 180-192 (1976).
Miyazaki, T., et al., "Structural Examination of Antitumour, Water-Soluble Glucans from Grifora umbellata by Use of Four Types of Glucanase," Carbohydrate Research, 65: 235-243 (1978).
Reiskind, J.B. and Mullins, J.T., "Molecular Architecture of the Hyphal Wall of Achlya ambisexualis Raper. II. Ultrastructural Analyses and a Proposed Model," Can. J. Microbiol., 27: 1100-1105 (1981).
Latge, J.P. et al., "Composition Chimique et Ultrastructure des Parois des Corps Hyphaux et des Azygospores de Conidiobolus obscurus," Can. J. Microbiol., 30: 1507-1521 (1984).
Sherwood, E.R. et al., "Soluble Glucan and Lymphokine-Activated Killer (LAK) Cells in the Therapy of Experimental Hepatic Metastases," Chemical Abstracts 108: 179752v (1988).
Hara, C. et al., "A Branched (1.fwdarw.3)-.beta.-D-Glucan from a Water Extract of Dictyophora indusiata FISCH," Carb. Res. 145: 237-246 (1986).
Goldman, R., "Introduction of a .beta.-1,3-Glucan Receptor in P388D1 Cells Treated with Retinoic Acid of 1,25-dihydroxyvitamin D.sub.3," Immunology 63: 319-324 (1988).
Konopski, A. et al., "Phagocytosis of .beta.-1,3-Glucan-Derivatized Microbeads by Mouse Peritoneal Macrophages Involves Three Different Receptors," Scand. J. Immunol. 33: 297-306 (1991).
Bacon, J. et al., "The Glucan Components of the Cell Wall of Baker's Yeast ( Saccharomyces cerevisiae) Considered in Relation to its Ultrastructure," Biochem. J. 114: 557-567 (1969).
Vestnik Federalniho Uradu Pro Vynalezy 10: 111 (1989).
Vestnik Federalniho Uradu Pro Vynalezy 11: 122-123 (1989).
Abel, G. and J.K. Czop, "Activation of Human Monocyte GM-CSF and TNF-.alpha. Production by Particulate Yeast Glucan," International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Chihara, G. et al., "Lentinan as a Host Defense Potentiator (HPD)," Int. J. Immunotherapy V(4): 145-154 (1989).
Sherwood, E.R. et al., "Enhancement of Interleukin-1 and Interleukin-2 Production by Soluble Glucan," Int. J. Immunopharm. 9(3): 261-267 (1987).
Williams, D.L. et al., "Pre-Clinical Safety Evaluation of Soluble Glucan," Int. J. Immunopharmac. 10(4): 405-414 (1988).
Browder, W. et al., "Beneficial Effect of Enhanced Macrophage Function in the Trauma Patient," Ann. Surg. pp. 605-613 (1990).
Shiota, M. et al., "Comparison of .beta.-Glucan Structures in a Cell Wall Mutant of Saccharomyces cerevisiae and the Wild Type", J. Biochem. 98:1301-1307 (1985).
James et al., "PGG-A Novel Class of Macrophage Activating Immunomodulators", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Katzen et al., "PGG, A Glucose Polymer, Primes Interleukin-1 and Tumor Necrosis Factor Production . . . ", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Shah et al., "Influence of PGG on the Phagocytosis of Staphylococcus aureus of Escherichia coli . . . " International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Onderdonk, A.B., "Effect of a New Carbohydrate Polymer on Survival in a Mouse Model for Experimental E. coli sepsis", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
A. Arbo and J.I. Santos, "Effect of PGG on Neutrophil (PMN) Function in Experimental Malnutrition", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Easson, Jr. D. Davidson
James Spiros
Ostroff Gary R.
Alpha-Beta Technology, Inc.
Kight John
White Everett
LandOfFree
Method for producing underivatized, aqueous soluble .beta.(1-3) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing underivatized, aqueous soluble .beta.(1-3) , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing underivatized, aqueous soluble .beta.(1-3) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309571